RYTMRhythm Pharmaceuticals, Inc.
$89.19-20% 1Y
$89.19
$75.8252 weeks$117.62
Is the price fair?
What RYTM's price assumes
Rhythm Pharmaceuticals, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 25.6× revenue.
25.6
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 59.6
Price / book · today's price, trailing year to Jun 30, 2026
- EV / sales
- 24.7
EV / sales
Details›
- Price / booktoday's price, trailing year to Jun 30, 2026
- 59.6
- EV / EBIToperating margin −84%: the multiple describes the denominator
- not meaningful
- EV / salestoday's price, trailing year to Jun 30, 2026
- 24.7
- Market capitalisation68.9 million shares, counted Aug 1, 2026
- $6.14B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.